મેટ્રિક્સ
 
 
Moneycontrol.com ભારત | એકાઉન્ટીંગ નીતિ > Vanaspati & Oils > એકાઉન્ટીંગ નીતિ ને અનુસરો દ્રારા મિહિજમ વનસ્પતિ - બીએસઈ: 519481, ઍનઍસઈ : N.A

મિહિજમ વનસ્પતિ

બીએસઈ: 519481  |  ઍનઍસઈ : N.A  |  ISIN: INE521C01013  |  Vanaspati & Oils

શોધો મિહિજમ વનસ્પતિ કનેક્શન � માર્ચ 11
એકાઉન્ટીંગ નીતિ વર્ષ : માર્ચ '12
(a) Basis of Accounting

The financial statements have been prepared in conformity with Generally Accepted accounting principles (GAAP). Accounts have been prepared on historical cost convention and on the accounting principle of going concern.

(b) Use of Estimates

The preparation of financial statements in conformity with GAAP requires estimates & assumptions to be made that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities on the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates and differences between actual results and estimates are recognized in the periods in which the results are known/materialize.

(c) Fixed Assets

Fixed assets are capitalised at cost, inclusive of duties, taxes, freight, installation and other incidental expenses related to acquisition thereof. Assets costing Rs. 5 000/- (Rupees five thousand only) or less are being charged to Profit & Loss account under appropriate heads.

(d) Depreciation

i) Depreciation on Fixed Assets has been provided on straight line method at the rates prescribed in Schedule XIV to the Companies Act, 1956 as amended.

ii) Depreciation on fixed assets added/disposed of during the year has been provided on pro- rata basis with reference to the date of addition/put to use/disposal.

iii) Extra shift depreciation, wherever applicable has been calculated on actual shift basis.

iv) Depreciation includes amount amortised in respect of original cost of Leasehold Land over its residual lease period.

(e) Employee Benefits

The estimated accrued liability in respect of payment of Gratuity and leave entitlements has not been ascertained and the same will be accounted for as and when paid.

(f) Revenue Recognition

i) The Company adopts the accrual basis of accounting in the preparation of the accounts except for Insurance claims accounted for on cash basis and excise duty & custom duty accounted for on clearance basis.

ii) Selling expenses and the differential sale in respect of consignment sale is accounted for on the basis of relevant sale statement received from Consignment Agents until the finalisation of accounts.

(g) Contingent Liability

Contingent liabilities are not provided for in the accounts and are shown separately in the notes on account.

(h) Inventories

Basis of valuation: Finished Goods : At average cost or realizable value whichever is lower

By-Products : At realizable value

Stock with Agents : At average cost or realizable value whichever is lower

Work-in-process : At estimated value

Raw Materials : At cost

Stock in transit : At cost incurred

Stores & Spares : At cost

(i) Borrowing Costs

Borrowing costs are charged to Profit & Loss Account except in cases where the borrowings are directly attributable to the acquisition, construction or production of qualifying asset.

(j) Current Tax

Provision for current tax is made after taking into consideration benefits admissible under the provisions of the Income Tax Act 1961.

(k) Deferred Tax

Deferred tax resulting from timing differences between book and taxable profits is recognized using the tax rates & laws that have been enacted or substantially enacted as on the Balance Sheet date. As a matter of prudence, deferred tax asset is recognized only to the extent that there is deferred tax liability on account of such timing difference.

(l) Foreign Currency Transaction

Transactions in foreign currency are recorded at the exchange rate prevailing at the time of transaction. Current assets and liabilities are restated at the rate prevailing at the year end or at the forward rate, where forward cover has been taken and the difference between the year end rate and the exchange rate at the date of transaction is recognized as Income or Expense in the profit and loss account.

(m) Earnings Per Share

Earnings per share is calculated by dividing the net profit or loss for the year after prior period adjustments attributable to shareholders by the weighted average number of equity shares outstanding during the year.

(n) Provisions, Contingent Liabilities and Contingent Assets

As per AS-29 - Provisions, Contingent Liabilities and Contingent Assets the company recognizes provisions only where reliable estimates can be made for probable outflow of resources to settle the present obligation as a result of past events and the same is reviewed at each Balance Sheet date. Contingent Liabilities are generally not provided for in the accounts and are shown separately in the Notes on Accounts. Contingent Assets are neither recognized nor disclosed in the financial statements since this may result in the recognition of income that may never be realized

(o) Impairment

Impairment loss is recognized wherever the carrying amount of an asset is in excess of its recoverable amount and the same is recognized as an expense in the statement of profit & loss and carrying amount is reduced to its recoverable amount.

(p) Research and Development Expenditure

Revenue expenses are charged to the Profit & Loss Account in the year in which they are incurred.

સ્તોત્ર: રેલીગેર ટેકનોવા


ન્યૂઝ ફ્લૅશ

  • સન ફાર્મા અમેરિકામાં Imatinib Mesylate લોન્ચ
  • કારોબાર : શૅર્સ સંબધિત પ્રશ્નો પૂછવા માટે BH (SPACE) STOCK સાથે તમારું નામ અને ફોન નંબર લખીને મેસેજ કરો 51818 પર
  • કારોબાર : BH (SPACE) આપના સ્ટોકની વિગત, સાથે જ આપનું નામ લખી 51818 પર મેસેજ કરો અને અમારા ટોલ ફ્રી નંબર 1800-4190-709 પર કાૅલ કરો અને જવાબ મેળવો અમારા ખાસ શાૅ બજાર હેલ્પલાઇનમાં સોમવારથી શુક્રવાર સવારે 11.30 કલાકે
  • કારોબાર : પર્સનલ ફાઇનાન્સને લગતા તમારા કોઈ પ્રશ્ન હોય તો તમે અમને money@network18online.com પર મોકલી શકો છો. તમારા સવાલના જવાબ મની મૅનેજરમાં આપવામાં આવશે
  • કારોબાર : ચીનના આર્થિક આંકડાઓ જાન્યુઆરી Caixin ફાઈનલ મેન્યુફેક્ચરીંગ PMI 48.2 થી વધી 48.4 (MoM)
  • કારોબાર : US FDAની મંજૂરી મળી ઓરોબિન્દો ફાર્માને ડાયાબિટિશની દવા Saxagliptin માટે મંજૂરી મળી
  • કારોબાર : US FDAની મંજૂરી મળી ડો.રેડ્ડીઝને બેક્ટેરિયલ ઈન્ફેક્શનની દવા ડોક્સીસાયક્લીન માટે મંજૂરી મળી
  • કારોબાર : US FDAની મંજૂરી મળી માઈગ્રેનની દવા Sumatriptan માટે ડો.રેડ્ડીઝને મંજૂરી મળી
  • કારોબાર : જાપાનના આર્થિક આંકડાઓ જાન્યુઆરીમાં મેન્યુફેક્ચરીંગ PMI 52.6 થી ઘટી 52.3 (MoM)
  • કારોબાર : વકરાંગીએ ટાટા AIG જનરલ ઈન્શ્યોરન્સ કંપની સાથે કરાર કર્યા